EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial

Alieske Kleeven, Yasmine M J Jonis, Olivia Currie, Joost Wolfs, Merel Kimman, Hanneke Tielemans, René R W J van der Hulst, Stefan Hummelink iD, Shan Shan Qiu iD

British Journal of Surgery · 2026

DOI: 10.1093/bjs/znag062 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Surgery, 2026. Verfasst von Alieske Kleeven und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Lymphatic Vessels, Breast Cancer Lymphedema, Conservative Treatment, Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw, Maastricht University Medical Centre.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lymphaticovenous anastomosis (LVA) is an increasingly applied microsurgical option for lymphoedema. The aim of this study was to evaluate the cost-effectiveness of LVA combined with complex decongestive therapy (CDT) versus CDT alone for breast cancer-related lymphoedema (BCRL).

Methods

A cost-effectiveness analysis was performed as a pre-specified secondary outcome of an RCT comparing LVA combined with CDT versus CDT alone. The primary outcome of the trial was health-related quality of life (HRQoL). A societal perspective with a 2-year time horizon was adopted. Quality-adjusted life-years (QALYs) were derived from the EuroQol five-dimension, five-level (EQ-5D-5L) questionnaire. Uncertainty was assessed using bootstrapping and sensitivity analysis. Data were collected from four Dutch hospitals. The primary outcome was the incremental cost-effectiveness ratio (ICER).

Results

One hundred female patients were included (mean age 58.5 years). Over 2 years, mean total costs were €16 234 (LVA) versus €14 293 (CDT); adjusted mean difference €78 (95% c.i. −€6044 to €6200). Mean(s.e.) QALYs were 1.636(0.003) (LVA) versus 1.579(0.002) (CDT); adjusted mean difference 0.045 (95% c.i. −0.021 to 0.112). The ICER from a societal perspective was €1716/QALY, with probabilities of cost-effectiveness of 0.60 and 0.71 at the €20 000 and €50 000 willingness-to-pay thresholds respectively. From a healthcare perspective, the ICER was €59 679/QALY, with probabilities of cost-effectiveness of 0.08 and 0.42 at the same thresholds respectively.

Conclusion

LVA combined with CDT was more costly than CDT alone, but societal costs were limited during the 2-year follow-up interval. The LVA group acquired slightly more QALYs. From a societal perspective, LVA combined with CDT has the potential to be cost-effective, particularly when performed under local anaesthesia. Registration number NCT02790021 (http://www.clinicaltrials.gov).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic VesselsBreast Cancer LymphedemaConservative TreatmentBreast NeoplasmsHumansFemaleCost-Benefit AnalysisCost-Effectiveness AnalysisMiddle AgedAnastomosis, SurgicalQuality-Adjusted Life YearsQuality of LifeNetherlandsAgedVeinsTreatment Outcome

Autor:innen und Institutionen

  • Department of Plastic, Reconstructive, and Hand Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.
  • Department of Plastic Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • GROW, School for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
  • Faculty of Health, Medicine, and Life Sciences, Maastricht University, Maastricht, The Netherlands.
  • Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.

ORCID-Profile: Stefan Hummelink, Shan Shan Qiu

Förderung

  • ZonMw
  • Maastricht University Medical Centre

Zitieren

APA

Kleeven, A., Jonis, Y. M. J., Currie, O., Wolfs, J., Kimman, M., Tielemans, H., van der Hulst, R. R. W. J., Hummelink, S., & Qiu, S. S. (2026). Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial. British Journal of Surgery. https://doi.org/10.1093/bjs/znag062

Vancouver

Kleeven A, Jonis YMJ, Currie O, Wolfs J, Kimman M, Tielemans H, et al. Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial. British Journal of Surgery. 2026. doi:10.1093/bjs/znag062

BibTeX
@article{Kleeven2026,
  author = {Kleeven, Alieske and Jonis, Yasmine M J and Currie, Olivia and Wolfs, Joost and Kimman, Merel and Tielemans, Hanneke and van der Hulst, René R W J and Hummelink, Stefan and Qiu, Shan Shan},
  title = {Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial},
  journal = {British Journal of Surgery},
  year = {2026},
  doi = {10.1093/bjs/znag062}
}
Kostenlos starten →